ASMI Media Release – 2018 ASMI AGM elects new Board Director

2018 ASMI AGM elects new Board Director
28 November 2018

The Australian Self Medication Industry (ASMI) held its AGM in Parliament House, Canberra, yesterday.

Doug Cunningham, Managing Director, Johnson & Johnson Pacific and Mark Sargent, General Manager, ANZ Consumer Health Bayer Australia were re-elected to the Board of Directors.

Joining the Board of Directors for the first time, also elected at the AGM, is Theresa Agnew, Area General Manager, Australia & New Zealand, GSK Consumer Healthcare.

ASMI Chairperson, Lindsay Forrest, congratulated the Directors on their election and welcomed them to the Board.

“After a successful 2018, ASMI is in a strong position to continue advocating for greater Self Care over the year ahead with the re-election of Doug and Mark, and the election of Theresa, yesterday in Canberra” explained Lindsay Forrest.

Elected Directors hold office for two years, and join the existing Board of Directors:

  • Robert Barnes, Head of Nutritionals & Consumer OTC, Aspen Pharmacare
  • Glenn Cochran, Regional Director Australia & NZ – Health, Reckitt Benckiser
  • Lindsay Forrest, Consultant (Chairperson)
  • Andrew Jenkin, General Manager, Pfizer Consumer Healthcare
  • Alan Oppenheim, Managing Director, Ego Pharmaceuticals Pty Ltd
  • Seona Wallace, Managing Director, HealthOne

Leave a Reply

Your email address will not be published. Required fields are marked *